- Report
- April 2025
- 550 Pages
Global
€2620EUR$2,950USD£2,289GBP
- Report
- September 2025
- 393 Pages
Global
From €5152EUR$6,004USD£4,350GBP
- Report
- March 2025
- 367 Pages
Global
From €5152EUR$6,004USD£4,350GBP
- Report
- June 2025
- 293 Pages
Global
From €4262EUR$4,799USD£3,724GBP
- Report
- February 2025
- 138 Pages
Global
From €2000EUR$2,412USD£1,809GBP
- Report
- September 2025
- 254 Pages
Global
From €4396EUR$4,950USD£3,842GBP
- Report
- September 2025
- 380 Pages
Global
From €4396EUR$4,950USD£3,842GBP
- Report
- August 2025
- 383 Pages
Global
From €4396EUR$4,950USD£3,842GBP
- Report
- August 2025
- 354 Pages
Global
From €4396EUR$4,950USD£3,842GBP
- Report
- August 2025
- 100 Pages
Global
From €2931EUR$3,300USD£2,561GBP
- Report
- October 2024
- 199 Pages
From €3149EUR$3,545USD£2,751GBP
€3498EUR$3,939USD£3,057GBP
- Report
- April 2025
- 388 Pages
Global
From €4130EUR$4,650USD£3,609GBP
- Report
- April 2025
- 162 Pages
Global
From €4130EUR$4,650USD£3,609GBP
- Report
- May 2025
- 170 Pages
Global
From €4130EUR$4,650USD£3,609GBP
- Report
- February 2025
- 225 Pages
Global
From €3197EUR$3,600USD£2,794GBP
€3997EUR$4,500USD£3,492GBP
- Report
- December 2025
- 457 Pages
Global
From €5196EUR$5,850USD£4,540GBP
- Report
- December 2025
- 231 Pages
Global
From €5196EUR$5,850USD£4,540GBP
- Report
- October 2025
- 150 Pages
Global
From €5284EUR$5,950USD£4,618GBP
- Report
- October 2025
- 120 Pages
Global
From €5284EUR$5,950USD£4,618GBP
- Report
- October 2025
- 120 Pages
Global
From €5284EUR$5,950USD£4,618GBP

The Antibodies market is a subset of the Immune Disorders Drugs market, which focuses on treatments for conditions related to the immune system. Antibodies are proteins produced by the body to fight off foreign substances, such as bacteria and viruses. They are used to treat a variety of immune-related conditions, including autoimmune diseases, allergies, and cancer. Antibodies can be used in combination with other drugs, such as steroids, to reduce inflammation and improve symptoms. They can also be used to target specific cells or proteins in the body, allowing for more targeted treatments.
The Antibodies market is highly competitive, with a number of companies offering a variety of products. Companies such as AbbVie, Amgen, and Biogen are leading the way in developing and marketing antibodies for the treatment of immune-related conditions. Other companies, such as Genentech and Regeneron, are also active in the market, offering a range of products for different conditions. Show Less Read more